NEW ALKYNYLATED QUINAZOLIN COMPOUNDS AS MMP-13 INHIBITORS

Details for Australian Patent Application No. 2002331362 (hide)

Owner WARNER-LAMBERT COMPANY LLC

Inventors GAUDILLIERE, Bernard; JACOBELLI, Henry; WILSON, Michael, William; PICARD, Joseph, Armand

Pub. Number AU-A-2002331362

PCT Number PCT/EP02/08475

PCT Pub. Number WO2004/007469

Filing date 12 July 2002

Wipo publication date 2 February 2004

International Classifications

C07D 239/96 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 031/505 - Pyrimidines

A61P 019/02 Drugs for skeletal disorders

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07F 007/18 Compounds containing elements of the 4th Group of the Periodic System

Event Publications

6 February 2003 Complete Application Filed

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2002331362

7 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331363-MEDICAL INSTRUMENT CONSISTING OF TWO PARTS WITH A CONNECTING DEVICE FOR THE CONNECTION THEREOF

2002331361-Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments